COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 131 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4 | -20.0% | 120 | 0.0% | 0.00% | – |
| Q1 2024 | $5 | 0.0% | 120 | -44.2% | 0.00% | – |
| Q4 2022 | $5 | -99.8% | 215 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 215 | -6.9% | 0.00% | – |
| Q2 2022 | $4,000 | -60.0% | 231 | -53.8% | 0.00% | – |
| Q1 2022 | $10,000 | +11.1% | 500 | +3.7% | 0.00% | – |
| Q4 2021 | $9,000 | +80.0% | 482 | +79.2% | 0.00% | – |
| Q3 2021 | $5,000 | -16.7% | 269 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 269 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -97.2% | 269 | -97.8% | 0.00% | -100.0% |
| Q2 2020 | $214,000 | +7.5% | 12,200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $199,000 | -67.5% | 12,200 | -77.1% | 0.00% | -50.0% |
| Q3 2019 | $612,000 | +25.2% | 53,300 | +65.0% | 0.00% | 0.0% |
| Q1 2019 | $489,000 | -11.9% | 32,300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $555,000 | – | 32,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $32,405,000 | 8.36% |
| SECTORAL ASSET MANAGEMENT INC | 1,156,934 | $19,865,000 | 2.70% |
| 1492 Capital Management LLC | 150,189 | $2,579,000 | 2.31% |
| Eventide Asset Management | 2,207,610 | $37,905,000 | 1.68% |
| J. Goldman & Co LP | 1,066,847 | $18,318,000 | 1.41% |
| HAMILTON LANE ADVISORS LLC | 89,975 | $1,545,000 | 1.35% |
| Rock Springs Capital Management LP | 1,605,105 | $27,560,000 | 1.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 932,126 | $16,005,000 | 0.58% |
| Opaleye Management Inc. | 80,000 | $1,373,000 | 0.51% |
| Cortina Asset Management, LLC | 456,036 | $7,830,000 | 0.48% |